Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TELA Bio (TELA) FCF Margin (2018 - 2025)

Historic FCF Margin for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to 28.66%.

  • Bio's FCF Margin rose 193700.0% to 28.66% in Q3 2025 from the same period last year, while for Sep 2025 it was 40.88%, marking a year-over-year increase of 261900.0%. This contributed to the annual value of 61.45% for FY2024, which is 94900.0% up from last year.
  • Bio's FCF Margin amounted to 28.66% in Q3 2025, which was up 193700.0% from 39.7% recorded in Q2 2025.
  • Bio's FCF Margin's 5-year high stood at 28.66% during Q3 2025, with a 5-year trough of 146.45% in Q1 2021.
  • In the last 5 years, Bio's FCF Margin had a median value of 74.91% in 2021 and averaged 79.01%.
  • Its FCF Margin has fluctuated over the past 5 years, first soared by 1070900bps in 2021, then plummeted by -393100bps in 2022.
  • Quarter analysis of 5 years shows Bio's FCF Margin stood at 117.95% in 2021, then rose by 20bps to 94.9% in 2022, then soared by 30bps to 66.22% in 2023, then skyrocketed by 33bps to 44.17% in 2024, then soared by 35bps to 28.66% in 2025.
  • Its FCF Margin stands at 28.66% for Q3 2025, versus 39.7% for Q2 2025 and 52.68% for Q1 2025.